Sunnyvale, CA-headquartered molecular diagnostic company Cepheid launched its first manufacturing facility in Bangalore.
The 77,000 square-foot facility will manufacture the company’s Xpert tuberculosis testing cartridges for India and other countries,
The launch of the new manufacturing facility in India represents a significant milestone for Cepheid to provide accessible and high-quality molecular diagnostic solutions to health care providers and patients in the region, it said.
Laurent Bellon, senior vice president, Operations, Cepheid USA, said, “We are thrilled to announce the launch of our first manufacturing unit in India. The Make in India program represents our vision of furthering India’s growth and development in the molecular diagnostic ecosystem. We are proud to be a critical partner in the country’s efforts to improve healthcare outcomes and eliminate TB. This new manufacturing facility illustrates our strong commitment to India.”
The local manufacturing of components will make Cepheid’s MTB kits more accessible while strengthening the broader molecular diagnostics production capabilities in the country, the company noted.
Last updated: December 26th, 2025
